- Home
- MSM vs ACLX Comparison
MSM vs ACLX Comparison
Compare MSM & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MSM | ACLX |
|---|---|---|
| Founded | 1941 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 3.7B |
| IPO Year | 1996 | 2022 |
Fundamental Metrics
Financial Performance| Metric | MSM | ACLX |
|---|---|---|
| Price | $91.09 | $114.35 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 15 |
| Target Price | $91.00 | ★ $115.85 |
| AVG Volume (30 Days) | 513.0K | ★ 3.6M |
| Earning Date | 04-08-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.86% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.93 | N/A |
| Revenue | ★ $3,363,817,000.00 | $22,286,000.00 |
| Revenue This Year | $5.96 | $329.40 |
| Revenue Next Year | $5.23 | $151.37 |
| P/E Ratio | $97.03 | ★ N/A |
| Revenue Growth | ★ 4.99 | N/A |
| 52 Week Low | $68.10 | $47.86 |
| 52 Week High | $96.99 | $114.80 |
Technical Indicators
Market Signals| Indicator | MSM | ACLX |
|---|---|---|
| Relative Strength Index (RSI) | 49.71 | 83.30 |
| Support Level | $91.09 | $66.06 |
| Resistance Level | $93.83 | $114.80 |
| Average True Range (ATR) | 2.55 | 0.35 |
| MACD | -0.47 | -0.30 |
| Stochastic Oscillator | 51.24 | 65.68 |
Price Performance
Historical ComparisonAbout MSM MSC Industrial Direct Company Inc.
Founded in 1941, MSC Industrial Direct originally manufactured and sold cutting tools to metalworking shops in New York. Through a series of acquisitions and organic expansions, MSC has grown into an industrial distribution powerhouse with a focus on specialized metalworking products and services. The firm also distributes a wide breadth of maintenance, repair, and operations supplies. MSC primarily operates in North America, where it derives over 95% of its revenue.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.